"G(M1) Ganglioside" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A specific monosialoganglioside that accumulates abnormally within the nervous system due to a deficiency of GM1-b-galactosidase, resulting in GM1 gangliosidosis.
Descriptor ID |
D005677
|
MeSH Number(s) |
D09.400.410.420.025.475.390 D10.390.470.025.475.390 D10.570.877.360.025.475.390
|
Concept/Terms |
G(M1) Ganglioside- G(M1) Ganglioside
- Monosialosyl Tetraglycosyl Ceramide
- Ceramide, Monosialosyl Tetraglycosyl
- Tetraglycosyl Ceramide, Monosialosyl
|
Below are MeSH descriptors whose meaning is more general than "G(M1) Ganglioside".
Below are MeSH descriptors whose meaning is more specific than "G(M1) Ganglioside".
This graph shows the total number of publications written about "G(M1) Ganglioside" by people in this website by year, and whether "G(M1) Ganglioside" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 2 | 0 | 2 |
1997 | 0 | 1 | 1 |
1998 | 0 | 1 | 1 |
1999 | 0 | 1 | 1 |
2001 | 1 | 0 | 1 |
2002 | 2 | 2 | 4 |
2003 | 0 | 1 | 1 |
2014 | 0 | 1 | 1 |
2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "G(M1) Ganglioside" by people in Profiles.
-
De Chatterjee A, Mendez TL, Roychowdhury S, Das S. The assembly of GM1 glycolipid- and cholesterol-enriched raft-like membrane microdomains is important for giardial encystation. Infect Immun. 2015 May; 83(5):2030-42.
-
Zeng Y, Tarbell JM. The adaptive remodeling of endothelial glycocalyx in response to fluid shear stress. PLoS One. 2014; 9(1):e86249.
-
Wadehra M, Su H, Gordon LK, Goodglick L, Braun J. The tetraspan protein EMP2 increases surface expression of class I major histocompatibility complex proteins and susceptibility to CTL-mediated cell death. Clin Immunol. 2003 May; 107(2):129-36.
-
Twu C, Liu NQ, Popik W, Bukrinsky M, Sayre J, Roberts J, Rania S, Bramhandam V, Roos KP, MacLellan WR, Fiala M. Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathways. Proc Natl Acad Sci U S A. 2002 Oct 29; 99(22):14386-91.
-
Nashar TO, Betteridge ZE, Mitchell RN. Antigen binding to GM1 ganglioside results in delayed presentation: minimal effects of GM1 on presentation of antigens internalized via other pathways. Immunology. 2002 May; 106(1):60-70.
-
Popik W, Alce TM, Au WC. Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells. J Virol. 2002 May; 76(10):4709-22.
-
Yuan C, Furlong J, Burgos P, Johnston LJ. The size of lipid rafts: an atomic force microscopy study of ganglioside GM1 domains in sphingomyelin/DOPC/cholesterol membranes. Biophys J. 2002 May; 82(5):2526-35.
-
Nashar TO, Betteridge ZE, Mitchell RN. Evidence for a role of ganglioside GM1 in antigen presentation: binding enhances presentation of Escherichia coli enterotoxin B subunit (EtxB) to CD4(+) T cells. Int Immunol. 2001 Apr; 13(4):541-51.
-
Williams NA, Hirst TR, Nashar TO. Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic. Immunol Today. 1999 Feb; 20(2):95-101.
-
Hirst TR, Nashar TO, Pitman RS, Williams NA. Cholera toxin and related enterotoxins as potent immune modulators. Symp Ser Soc Appl Microbiol. 1998; 27:26S-34S.